FDA Inspection
Agnesian Healthcare IRBAgnesian Healthcare IRB – FDA Inspection, Nov 13, 2012
Record Details
This FDA Inspection record concerns Agnesian Healthcare IRB, with an inspection on November 13, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Agnesian Healthcare IRB
- Inspection Date
- November 13, 2012
- Product Type
- Drugs
View Company Profile
ID · b195dbd9-5f4b-4d87-95dd-b61b05dd68f1
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 807438
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
7- 21 CFR 56.115(a)(4)Copies of IRB/CI correspondence
- 21 CFR 56.115(a)(1)Copies of all research proposals and related documents
- 21 CFR 56.115(a)(6)Written procedures per 56.108(a) and (b)
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.109(b)Information given to subjects
- 21 CFR 56.109(e)IRB approvals/disapprovals - general
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Agnesian Healthcare IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| June 17, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Agnesian Healthcare IRB
- FDA Inspection 1071800 - 2018-11-05
- FDA Inspection 884359 - 2014-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.